1. Trump Approves IRAN ATTACK PLAN, Holds Final Order, Iran May Meet At White House | Timcast IRL

    Trump Approves IRAN ATTACK PLAN, Holds Final Order, Iran May Meet At White House | Timcast IRL

  2. MUST WATCH! KAROLINE LEAVITT HOSTS A MAJOR PRESS CONFERENCE FROM THE WHITE HOUSE! AND MORE NEWS!

    MUST WATCH! KAROLINE LEAVITT HOSTS A MAJOR PRESS CONFERENCE FROM THE WHITE HOUSE! AND MORE NEWS!

    340
    7
    12.7K
    9
  3. Don’t Miss Out: 10 FREE Plugins + Drum VSTs to Level Up Your Music! BFD 3.5 TRIAZ Drum Machine UJAM

    Don’t Miss Out: 10 FREE Plugins + Drum VSTs to Level Up Your Music! BFD 3.5 TRIAZ Drum Machine UJAM

    10
  4. Prototype 92: David Freese triples in a 9th inning tie

    Prototype 92: David Freese triples in a 9th inning tie

    4
  5. Introducing POW Algo Alerts

    Introducing POW Algo Alerts

    2
    0
    67
    1
  6. Aurora Crashes 25% As Q4 2025 Earnings Disappoint With Accounting Errors

    Aurora Crashes 25% As Q4 2025 Earnings Disappoint With Accounting Errors

    13
    1
  7. Understanding Both XRP Canadian Spot ETFs That Launched Today (XRPP & XRPQ)

    Understanding Both XRP Canadian Spot ETFs That Launched Today (XRPP & XRPQ)

    3
    0
    89
    2
  8. Tilray $0.32USD Target Inching Closer, TLRY Analysis & Price Prediction

    Tilray $0.32USD Target Inching Closer, TLRY Analysis & Price Prediction

    10
    1
  9. Aurora Q4 & 2025 Earnings Prep & Estimates, ACB Analysis & Price Prediction

    Aurora Q4 & 2025 Earnings Prep & Estimates, ACB Analysis & Price Prediction

    7
  10. High Tide Q2 2025 Earnings Miss Estimates & HITI Stock Analysis

    High Tide Q2 2025 Earnings Miss Estimates & HITI Stock Analysis

    21
    1
  11. 🚨XRP Spot ETF Launching In Canada July 18th 🚨 XRPP Purpose Investments

    🚨XRP Spot ETF Launching In Canada July 18th 🚨 XRPP Purpose Investments

    1
    1
    65
    1
  12. XRP: The Time Has Come... Ripple Case Ending This Week & ETFs Galore?

    XRP: The Time Has Come... Ripple Case Ending This Week & ETFs Galore?

    2
    0
    89
    1
  13. Crispr Therapeutics $23 or $53 Next Target? CRSP Stock Analysis

    Crispr Therapeutics $23 or $53 Next Target? CRSP Stock Analysis

    43
    1